Table 1.

Adverse Events Occurring in ≥ 2% of Edaravone-Treated Patients and ≥ 2% More Frequently Than in Placebo Patients^*17

Adverse Event	Edaravone (n = 184) %	Placebo (n = 184) %
Contusion	15	9
Gait disturbance	13	9
Headache	10	6
Dermatitis	8	5
Eczema	7	4
Respiratory failure, respiratory disorder, hypoxia	6	4
Glycosuria	4	2
Tinea infection	4	2

^*Data from pooled, placebo-controlled trials.